Literature DB >> 20519053

Examination of the physical and psychosocial determinants of health behaviour in 4-5-year-old children with congenital cardiac disease.

Frank A Casey1, M Stewart, C G McCusker, M L Morrison, B Molloy, N Doherty, B G Craig, A J Sands, N Rooney, H C Mulholland.   

Abstract

OBJECTIVES: To assess the general health and activity levels of 4- and 5-year-old children after intervention for congenital cardiac disease.
METHODS: Health behaviour outcomes were assessed in 91 children who had surgery or catheter intervention for congenital cardiac disease. The children were classified into four groups according to severity. The main parameters of classification were the presence of residual symptoms, frequency of visits to general practitioner or the Accident and Emergency Department, and ability to participate in physical activity according to a calculated "activity score".
RESULTS: Children had very few residual symptoms after "corrective surgery". Those with complex congenital cardiac disease post-Fontan-type repair still had symptoms on average 18.2 days per month. Surprisingly, the complex group had fewer days "sick" from non-cardiac causes and had fewer visits to general practitioner or Accident and Emergency Departments. Regression analysis indicates that three variables had significant relevance to the general practitioner or Accident and Emergency visits: complex congenital cardiac disease, fewer visits; Townsend score - more deprivation - more visits; and maternal worry - higher maternal worry score - more visits. Regression analysis indicates that lower activity score is significantly related to complex cardiac disease and higher maternal worry score.
CONCLUSIONS: The majority of this group of 4- and 5-year-old children had few residual symptoms and had good exercise tolerance. Maternal worry is a significant factor in influencing both activity levels and frequency of unscheduled health service demands - general practitioner or Accident and Emergency visits.

Entities:  

Mesh:

Year:  2010        PMID: 20519053     DOI: 10.1017/S1047951110000673

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  4 in total

1.  Associations between Infant and Parent Characteristics and Measures of Family Well-Being in Neonates with Seizures: A Cohort Study.

Authors:  Linda S Franck; Renée A Shellhaas; Monica Lemmon; Julie Sturza; Janet S Soul; Taeun Chang; Courtney J Wusthoff; Catherine J Chu; Shavonne L Massey; Nicholas S Abend; Cameron Thomas; Elizabeth E Rogers; Charles E McCulloch; Katie Grant; Lisa Grossbauer; Kamil Pawlowski; Hannah C Glass
Journal:  J Pediatr       Date:  2020-06       Impact factor: 4.406

2.  The Australian and New Zealand Fontan Registry Quality of Life Study: Protocol for a population-based assessment of quality of life among people with a Fontan circulation, their parents, and siblings.

Authors:  Kate H Marshall; Yves d'Udekem; David S Winlaw; Kim Dalziel; Susan R Woolfenden; Diana Zannino; Daniel S J Costa; Rachel Bishop; David S Celermajer; Gary F Sholler; Nadine A Kasparian
Journal:  BMJ Open       Date:  2022-09-20       Impact factor: 3.006

3.  Health-Related Quality of Life in Children, Adolescents, and Adults With a Fontan Circulation: A Meta-Analysis.

Authors:  Kate H Marshall; Yves D'Udekem; Gary F Sholler; Alexander R Opotowsky; Daniel S J Costa; Louise Sharpe; David S Celermajer; David S Winlaw; Jane W Newburger; Nadine A Kasparian
Journal:  J Am Heart Assoc       Date:  2020-03-16       Impact factor: 5.501

4.  The CHIP-Family study to improve the psychosocial wellbeing of young children with congenital heart disease and their families: design of a randomized controlled trial.

Authors:  Malindi van der Mheen; Ingrid M van Beynum; Karolijn Dulfer; Jan van der Ende; Eugène van Galen; Jorieke Duvekot; Lisette E Rots; Tabitha P L van den Adel; Ad J J C Bogers; Christopher G McCusker; Frank A Casey; Willem A Helbing; Elisabeth M W J Utens
Journal:  BMC Pediatr       Date:  2018-07-12       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.